businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 33
 
PresseMitteilungen

Biotech

Category / Pharmaceuticals & Biotech / Biotech

New Data Shows Potent in vitro Activity of VIBATIV(R) (telavancin) Against Difficult-to-Treat Clinical Pathogens, Including MRSA

DUBLIN, IRELAND: Greater in vitro Potency for VIBATIV Compared to Other Well-Known Antibiotics Such as Vancomycin, Daptomycin and Linezolid Highlighted in Presentations at ASM Microbe 2016 ...

Titan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine(R) for Opioid Dependence

PALM SPRINGS, CA: Poster on Analyses Presented at College of Problems of Drug Dependence 78th Annual Meeting ...

Theravance Biopharma to Present New Data Highlighting Potent in vitro Activity of VIBATIV(R) (telavancin) Against Difficult-to-Treat, Clinical Pathogens, Including MRSA, at ASM Microbe 2016 Conference

DUBLIN, IRELAND: Study Findings Highlight Greater in vitro Potency for VIBATIV Compared to Other Well-Known Antibiotics Such as Vancomycin, Daptomycin and Linezolid ...

Titan Pharmaceuticals Receives $15 Million Milestone Payment Following FDA Approval of Probuphine(R)

SOUTH SAN FRANCISCO, CA: More Than 800 Health Care Providers Already Certified Under the Probuphine REMS Program ...

Theravance Biopharma Reports Positive Results From Phase 1 Clinical Trial of TD-1473, a GI-Targeted Pan-Janus Kinase (JAK) Inhibitor

DUBLIN, IRELAND: Data Shows Favorable Safety and Tolerability of Single and Multiple Oral Doses of TD-1473 and Minimal Systemic Exposure in Healthy Subjects; Data Support Progression Into Phase 1b Clinical Trial in Ul ...


Page 33 von 247:  1 « ..  32 33 34  35  36  37  38  39  40  41  .. » 247





 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 92


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.